Symposium introduces new approach in diabetes type 2 management
Health scientists and doctors exchanged new approaches in the application of SGLT2 inhibitors in management of diabetes type 2 at an online symposium held recently by the Ho Chi Minh City Diabetes and Endocrinology Association and AstraZeneca.
More than 500 doctors and health professionals attended a symposium on management of diabetes type 2 in HCM City last week. — (Photo: the HCM City Diabetes and Endocrinology Association)
HCM City (VNS/VNA) - Health scientists and doctors exchanged newapproaches in the application of SGLT2 inhibitors in management of diabetes Type II at an online symposium held recently by the Ho Chi Minh City Diabetesand Endocrinology Association and AstraZeneca.
SGLT2 inhibitor is a class of medications that inhibit the reabsorption ofglucose in the kidneys and therefore lower blood sugar. SGLT2 inhibitors areused in the treatment of Type II diabetes mellitus.
The symposium focused discussion on DECLARE clinical study, which clearlyreduced proteinuria progression on diabetes type 2 through medicine with SGLT2iclass. The new approach can help their kidneys revert to a healthy stage early.
“DECLARE has shown a specific effect in reducing renal complications in diabeticpatients, including patients with or without atherosclerotic cardiovasculardisease. The early screening of kidney diseases will help early interventionand effective management of diabetes patients around the world - including Vietnam,thereby helping to improve kidney and cardiovascular prognosis for thepatient," said Dr. David Cherney from Toronto University, Canada.
With the participation of over 500 health professionals nationwide, the eventis part of activities to mark annual World Kidney Day on March 12.
Health experts also called for early detection and treatment of patients withdiabetes to minimise complications on hearts and kidneys. The introduction of anew medication in SGLT2i class is positive news for the medical community and patients.
In Vietnam, the number of diabetes patients who have been treated and managedby the health sector is still modest. The early prevention of complications onkidneys, comprehensive protection of the kidney and heart of patients becomeseven more urgent to maintain a stable life and reduce their economic burdenlater.
The health sector estimated that Vietnam has around 3.8 million diabetespatients, making up 6 percent of the country’s adult population./.
Nearly 1,900 different services and products at public hospitals will become around 30 percent more expensive in March, according to the Ministry of Health.
The MoH on November 14 introduced an application named “Diabetes Journey” to provide doctors with guidance on diagnosis of diabetes and recommendations for appropriate treatment options.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
More than 500 doctors and health professionals attended a symposium on management of diabetes type 2 in HCM City last week. — (Photo: the HCM City Diabetes and Endocrinology Association) 
